SCHEMBL7388646

SCHEMBL7388646

CCCCC(NC(=O)c1cccc(NS(=O)(=O)c2cccc3cccnc23)c1)C(=O)CNC(C)=O

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
TRPV1 Q8NER1 1/20 0.48
FABP1 P07148 2/20 0.46
ALDH1A1 P00352 3/20 0.45
PDE4B Q07343 1/20 0.44
NTSR1 P30989 2/20 0.43
GAA P10253 1/20 0.43
KCNA5 P22460 1/20 0.42
PKLR P30613 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
MAPT P10636 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TP53 P04637 1/20 0.41
HTT P42858 1/20 0.41
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7686601 0.90 TRPV1 (0.46) MEN1KMT2ATRPV1FABP1ALDH1A1
SCHEMBL7682371 0.88 FABP1 (0.46) MEN1KMT2ATRPV1FABP1ALDH1A1
SCHEMBL7665441 0.82 EGFR (0.46) MEN1KMT2ASMN1; SMN2
SCHEMBL7658785 0.82 ALDH1A1 (0.45) MEN1KMT2AALDH1A1GAASMN1; SMN2
SCHEMBL7789833 0.79 ALDH1A1 (0.50) MEN1KMT2ATRPV1FABP1ALDH1A1
SCHEMBL7787796 0.77 ALDH1A1 (0.52) MEN1KMT2AFABP1ALDH1A1PDE4B
SCHEMBL7661487 0.76 EGFR (0.47) MEN1KMT2A
SCHEMBL7659849 0.75 AKR1C3 (0.47) MEN1KMT2AALDH1A1GAASMN1; SMN2
SCHEMBL7689353 0.73 ALDH1A1 (0.44) MEN1KMT2AALDH1A1SMN1; SMN2MAPT
SCHEMBL7654043 0.73 ALDH1A1 (0.54) KMT2AALDH1A1GAAPKLRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed
EP-1073632-A1 SUBSTITUTED BENZAMIDES, THEIR PRODUCTION AND THEIR USE AS CYSTEINE PROTEASE INHIBITORS BASF AKTIENGESELLSCHAFT (DE) 2001-02-07 EP disclosed
WO-1999054293-A1 SUBSTITUTED BENZAMIDES, THEIR PRODUCTION AND THEIR USE AS CYSTEINE PROTEASE INHIBITORS BASF AKTIENGESELLSCHAFT (DE) 1999-10-28 WO disclosed